跳至主要内容
临床试验/PACTR202305473136570
PACTR202305473136570尚未招募3 期

Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised, double-blind, placebo-controlled trial

ondon School of Hygiene and Tropical Medicine0 个研究点目标入组 30,000 人开始时间: 2023年5月11日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
Female

入选标准

  • 1. Women thought to be aged 18 years or over admitted to hospital for a vaginal or caesarean birth
  • 2. One or more risk factors for PPH including but not limited to:
  • a) Maternal age = 35 years
  • b) Grand multiparity (at least 5 previous births)
  • c) Multiple pregnancies
  • d) Planned caesarean section
  • e) Preterm birth
  • f) Previous PPH
  • g) Hypertensive disease
  • h) Abnormal placental implantation
  • i) Antepartum haemorrhage or placental abruption present
  • j) Moderate or severe anaemia
  • k) Other risk factors

排除标准

  • 1. Tranexamic acid is clearly indicated (e.g. tranexamic acid has been given within 12 hours or planned to be given)
  • 2. Tranexamic acid is clearly contraindicated (e.g. known allergy to tranexamic acid)

研究者

发起方
ondon School of Hygiene and Tropical Medicine

相似试验

Tranexamic acid to prevent heavy bleeding after... | 临床试验